Replies to post #337 on electroCore, Inc. (ECOR)

[$Pistol Pete$]

$ECOR Product

gammaCore SapphireTM CV (nVNS) receives Emergency Use Authorization (EUA) to treat patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related dyspnea and reduced airflow.

[Magnum7419]

I am in today all I had to see was you and Pete :)

[Fezziwig2008]

ECOR for COVID 19 - "COVID-19 is a syndrome that includes more than just isolated respiratory disease, as severe acute respiratory syndrome–
coronavirus 2 (SARS-CoV2) also interacts with the cardiovascular, nervous, renal, and immune system at multiple levels,
increasing morbidity in patients with underlying cardiometabolic conditions and inducing myocardial injury or dysfunction.
Emerging evidence suggests that patients with the highest rate of morbidity and mortality following SARS-CoV2 infection have
also developed a hyperinflammatory syndrome (also termed cytokine release syndrome). We lay out the potential contribution of a dysfunction in autonomic tone to the cytokine release syndrome and related multiorgan damage in COVID-19. We hypothesize
that a cholinergic anti-inflammatory pathway could be targeted as a therapeutic avenue."

https://link.springer.com/content/pdf/10.1007/s12265-020-10031-6.pdf